Use of a compound for treating a respiratory disease in a mammal wherein the compound is a cannabinoid receptor modulator is disclosed. Compounds useful as cannabinoid receptor modulators for treating respiratory and non-respiratory leukocyte-activation associated diseases comprise compounds of formula (I),
1
in which A and B are nitrogen or carbon, provided only one of A and B is nitrogen; and R
1
-R
6
are as defined in the specification, wherein R
2
with R
5
may form a ring, and/or two R
4
groups may form a six-membered aryl or heteroaryl ring, optionally having a substituent R
6
forming a ring with R
3
.
本发明涉及使用一种大鼠呼吸系统疾病治疗化合物,其中该化合物是
大麻素受体调节剂。用于治疗呼吸和非呼吸白细胞激活相关疾病的
大麻素受体调节剂化合物包括式(I)的化合物,其中A和B是氮或碳,只有A和B中的一个是氮;R1-R6如规范所定义,其中R2和R5可以形成环,和/或两个R4基团可以形成一个六元杂环芳基或杂环芳基环,可选地具有一个R6取代基与R3形成一个环。